We are boosting our support for the multilateral vaccination drive, again providing our fair share to the ACT-Accelerator and COVAX in 2022. We are also continuing to donate substantial quantities of vaccines. This year, we have already provided 75 million doses – mostly via COVAX.
Germany was one of the founding members of the Country Coordinating Mechanism Access to COVID-19 Tools Accelerator (ACT-Accelerator) in April 2020 and remains its second-largest donor, with contributions totalling 3.3 billion euro so far. Germany’s support is channelled above all through the international COVAX Facility, which is part of the ACT-Accelerator and has to date distributed more than 1.4 billion doses to over 145 countries and territories.
Global vaccination rate remains below expectations
In spite of these efforts, vaccination rates in many countries do not meet the targets set by the World Health Organization. The reasons for this are varied, ranging from poor healthcare structures and inadequate information campaigns to insufficient logistics on the ground. That is why the German Government is funnelling the lion’s share of its contribution to the ACT-Accelerator this year to the Last Mile initiative. The aim is to help countries with low vaccination rates ensure that the vaccines supplied are actually used and get through to everyone who needs them.
It adopts a multi-pronged approach. On the one hand, it tackles misinformation and warns people of the dangers of catching COVID-19, so that more people decide to get vaccinated. On the other hand, it will also help to train health professionals, improve vaccine cold chains and storage options, and supply the necessary syringes, needles and protective equipment. The Federal Foreign Office is cooperating with partners such as UNICEF in this connection.
The issue of vaccine justice is also one of the priorities of Germany’s G7 Presidency, and is supported by the G7 partners.
The EU plans to donate at least 700 million doses. The G7 intends to supply a total of at least 870 million doses by the end of 2022. Most of these donations will go to COVAX, which will ensure that they are distributed fairly around the world.
Germany is engaged – worldwide
Germany and the EU are furthermore actively working to promote the production of vaccines in Africa in particular. Germany wants to provide funding to help expand vaccine production in countries including South Africa and Senegal.
With a view to learning from the pandemic and boosting global pandemic resilience in the future, Germany is also calling for the global health architecture with the WHO at its heart to be strengthened. Under WHO auspices, an international negotiating body is currently discussing a new agreement on the handling of pandemics; in addition, Germany is actively involved in discussions on the reform of the International Health Regulations. In order to put an end to the existing shortfalls in funding, Germany also supports the establishment of a new fund for pandemic prevention and preparedness.